2015
DOI: 10.1016/j.anpedi.2014.06.018
|View full text |Cite
|
Sign up to set email alerts
|

Feocromocitoma y paraganglioma en la infancia: a propósito de 2 casos

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 18 publications
0
5
0
1
Order By: Relevance
“…Nuclear medicine studies are reserved for patients with biochemical evidence of disease but with a negative CT or MRI and in suspected cases of metastatic disease. Even though there is no pathognomonic feature on CT scan to identify PGL, a heterogeneous, hypervascular mass with differential enhancement indicating areas of necrosis arising from the retroperitoneum is highly predictive [3]. …”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Nuclear medicine studies are reserved for patients with biochemical evidence of disease but with a negative CT or MRI and in suspected cases of metastatic disease. Even though there is no pathognomonic feature on CT scan to identify PGL, a heterogeneous, hypervascular mass with differential enhancement indicating areas of necrosis arising from the retroperitoneum is highly predictive [3]. …”
Section: Discussionmentioning
confidence: 99%
“…Preoperative biopsy should not be routinely performed due to the risk of an adrenergic crisis [5]. Alpha-adrenergic blockade for at least 4 weeks preoperatively may be administered in order to prevent and, if needed, to treat intra-operative catecholamine release [1, 3]. As neither signs nor symptoms of catecholamine release were observed in both cases prior to surgery and during biopsy, no alpha-adrenergic blockade was performed and no systemic repercussions were observed.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations